US Stocks
/
Immunome, Inc. Share Price
Immunome, Inc. Share Price

Immunome, Inc. Share Price

NASDAQ: IMNM | Mid Cap
$23.95
+$0.02 (0.06%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immunome, Inc. Stock Performance

Open
$23.66
Prev. Close
$23.93
Circuit Range
N/A
Day Range
$23.36 - $24.23
Year Range
$9.08 - $30.05
Volume
1,10,054
Average Traded
$23.73

Immunome, Inc. Share Price Today

As of 20 September 2026, Immunome, Inc.'s share price is $23.95. The stock opened at $23.66, compared to its previous close of $23.93. During today's trading session, Immunome, Inc.'s share price traded between $23.36 and $24.23, with an average price of $23.79. Over the past 52 weeks, the stock has recorded a high of $30.05 and a low of $9.08. In terms of performance, Immunome, Inc.'s share price has risen by 9.34% over the last six months and is up 104.66% on a year-on-year basis.

Immunome, Inc. Share Price Chart

$23.36$24.23
L
Show Current Price
H

Immunome, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.09B
PE Ratio (TTM)
-9.85
Dividend Yield
N/A
EPS (TTM)
$-2.43
Revenue (TTM)
$6.94M
Return On Equity (TTM)
-33.48%
Profit Margin
-3059.99%
Debt to Equity
0.07
Quarterly Earnings Growth YoY
-21.99%

Immunome, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$1.03M$2.36M$2.91M$2.93M$4.01M$0.00
Net Profit-$129.49M-$36.12M-$47.10M-$41.64M-$43.40M-$57.46M
Net Profit Margin-12584.26%-1528.00%-1618.56%-1423.10%-1080.87%N/A
Income ChangeN/A72.10%-30.39%11.59%-4.22%-32.40%

Immunome, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$14.02M$9.04M$6.94M
Net Profit-$106.81M-$292.96M-$212.39M
Net Profit Margin-761.92%-3240.38%-3059.99%
Income ChangeN/A-174.29%27.50%

About Immunome, Inc.

Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Immunome, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$27.23
$24.15
-16.39%
Aug 2026
$22.84
$28.89
+26.86%
Jul 2026
$20.65
$22.77
+7.36%
Jun 2026
$20.61
$21.21
-2.71%
May 2026
$23.09
$21.80
-4.97%
Apr 2026
$22.22
$22.94
+4.75%
Mar 2026
$21.91
$21.90
+0.18%
Feb 2026
$24.55
$21.86
-11.03%
Jan 2026
$21.48
$24.57
+14.28%
Dec 2025
$18.22
$21.50
+16.72%
Nov 2025
$16.14
$18.42
+14.62%
Oct 2025
$11.66
$16.07
+37.35%

IMNM Share Price FAQs

What is Immunome, Inc. share price today?

chevron-up
Immunome, Inc. share price today is $23.95 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Immunome, Inc. stock?

chevron-up
The 52 week high of Immunome, Inc. stock is $30.05, while the 52 week low is $9.08 as of 19 Sep '26.

What is IMNM's market capitalisation today?

chevron-up
IMNM market capitalisation is $2.09B as of September 20, 2026, at 9:39 am IST.

What is IMNM's net income for the last quarter?

chevron-up
IMNM's net income for the last quarter is -0.06B USD.

What is the 5 year returns of IMNM?

chevron-up
The 5 year returns of IMNM is -1.66% as on 19 Sep '26.

What is the high & low stock price of IMNM today?

chevron-up
IMNM stock price hit a high of $24.23 and low of $23.36 as of 19 Sep '26.

Can I buy IMNM shares in India?

chevron-up
Yes. You can buy IMNM in India by opening an international trading account.